David Yang

13PUBLICATIONS
117CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 24, 2026
A Phase 2 Study of Berzosertib in Combination with Carboplatin compared to Docetaxel with Carboplatin in Metastatic Castration-Resistant Prostate Cancer.

|Jul 08, 2026
Development and Validation of a Computational Histology Artificial Intelligence-Powered Biomarker in Metastatic Hormone-Sensitive Prostate Cancer on Randomized Phase III Trials.

|May 11, 2026
Immune Spatial Organization Predicts Distant Metastasis Risk in Aggressive Localized Prostate Cancer.

|Nov 28, 2025
Efficacy, safety, and predictive biomarkers of neoadjuvant nab-paclitaxel and pembrolizumab in hormone receptor-positive breast cancer: A randomized pilot trial.

Adrienne G Waks, Jingxin Fu, Xiangying Chu

|Aug 08, 2025
Implementing a context-augmented large language model to guide precision cancer medicine.

Hyeji Jun, Yutaro Tanaka, Shreya Johri

|Jun 06, 2025
Immune Spatial Organization Predicts Metastasis Risk in Aggressive Localized Prostate Cancer.

Pageof 3

Frequent Collaborators

6 joint publications

Eliezer Van Allen

3 joint publications

Mary-Ellen Taplin

3 joint publications

Anthony V D'Amico

3 joint publications

Alok K Tewari